Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lasagna

Showing results (121-130 of 199) with videos related to

Pageof 20
Sort By:
Clinical Pharmacology and Therapeutics|March 1, 1977
Toward the operational identification of adverse drug reactionsF E Karch, L Lasagna
Communications in Psychopharmacology|January 1, 1978
Low plasma levels of CPZ in patients chronically treated with neurolepticsR J Wyatt, L Lasagna
Clinical Pharmacology and Therapeutics|August 1, 1981
Estrogen patient package insert: medication acceptance despite negative attitudesM Weintraub, S Glickstein, L Lasagna
Clinical Pharmacology and Therapeutics|September 1, 1983
Evaluation of current clinical trial methodology in analgesimetry based on experts' opinions and analysis of several analgesic studiesK Sriwatanakul, L Lasagna, C Cox
Clinical Pharmacology and Therapeutics|August 1, 1982
The quantification of pain: an analysis of words used to describe pain and analgesia in clinical trialsK Sriwatanakul, W Kelvie, L Lasagna
Clinical Pharmacology and Therapeutics|March 1, 1975
Commentary. The normal volunteer in clinical investigation: how rigid should selection criteria be?P Joubert, L Rivera-Calimlim, L Lasagna
Clinical Pharmacology and Therapeutics|November 1, 1973
Effects of mode of management on plasma chlorpromazine in psychiatric patientsL Rivera-Calimlim, L Castañeda, L Lasagna
Journal of Clinical Pharmacology|January 1, 1978
Relationship of serum and myocardial digoxin concentration to electrocardiographic estimation of digoxin intoxicationT L Biddle, M Weintraub, L Lasagna
Journal of Clinical Pharmacology|August 1, 1989
Approvable letters in the FDA new drug approval processB W Richard, M Ulcickas, L Lasagna
JAMA|April 23, 1973
Compliance as a determinant of serum digoxin concentrationM Weintraub, W Y Au, L Lasagna
Pageof 20

Showing results (121-130 of 199) with videos related to

Sort By:
Pageof 20
Clinical Pharmacology and Therapeutics|March 1, 1977
Toward the operational identification of adverse drug reactionsF E Karch, L Lasagna
Communications in Psychopharmacology|January 1, 1978
Low plasma levels of CPZ in patients chronically treated with neurolepticsR J Wyatt, L Lasagna
Clinical Pharmacology and Therapeutics|August 1, 1981
Estrogen patient package insert: medication acceptance despite negative attitudesM Weintraub, S Glickstein, L Lasagna
Clinical Pharmacology and Therapeutics|September 1, 1983
Evaluation of current clinical trial methodology in analgesimetry based on experts' opinions and analysis of several analgesic studiesK Sriwatanakul, L Lasagna, C Cox
Clinical Pharmacology and Therapeutics|August 1, 1982
The quantification of pain: an analysis of words used to describe pain and analgesia in clinical trialsK Sriwatanakul, W Kelvie, L Lasagna
Clinical Pharmacology and Therapeutics|March 1, 1975
Commentary. The normal volunteer in clinical investigation: how rigid should selection criteria be?P Joubert, L Rivera-Calimlim, L Lasagna
Clinical Pharmacology and Therapeutics|November 1, 1973
Effects of mode of management on plasma chlorpromazine in psychiatric patientsL Rivera-Calimlim, L Castañeda, L Lasagna
Journal of Clinical Pharmacology|January 1, 1978
Relationship of serum and myocardial digoxin concentration to electrocardiographic estimation of digoxin intoxicationT L Biddle, M Weintraub, L Lasagna
Journal of Clinical Pharmacology|August 1, 1989
Approvable letters in the FDA new drug approval processB W Richard, M Ulcickas, L Lasagna
JAMA|April 23, 1973
Compliance as a determinant of serum digoxin concentrationM Weintraub, W Y Au, L Lasagna
Pageof 20